
What is the outlook for the global oncology market in 2024?
In IQVIA, we support customers in their mission to get drugs to patients. As such, we recognise the value of keeping track of the latest market trends, developments, and insights.
Modern healthcare is always changing. Whether as a result of innovations in efficiency or discoveries of new and better ways of caring for patients, it’s vital for any healthcare professional in this sphere to keep up-to-date with what’s going on.
Oncology is just one example of a rapidly advancing field. Read on to find out just what the global oncology market scene will look like in 2024 and beyond.
What advancements are shaping the future of oncology?
From increased spending on research and development (R&D) and greater competition to an increased focus on early detection, precision medicine, and immuno-oncology, numerous factors are driving the dynamic landscape of oncology to make this possible by closing the care gap in cancer care.
Research and development in oncology
In 2023, global spending in the oncology drugs market increased to $223 billion, $25 billion more than in 2022. Forecasts suggest this will reach $409 billion by 2028.
Additionally, more than two thousand new oncology clinical trials started in 2023 with significant promise for cancer treatment and novel modalities. R&D in oncology is seeing an increasing focus on targeted drugs with innovative mechanisms of action for treatment.
The NHS Cancer Drugs Fund (CDF) in the UK is funding some of the latest treatments. Almost one hundred thousand cancer patients have benefitted from early access to the most innovative treatments.
Making waves in new cancer treatments for 2024, the CDF has funded certain drugs for breast and prostate cancer, new immunotherapies for advanced womb cancer, cancer therapies for blood cancer, and more.
This surge in funding and innovation is exciting news for both oncology patients and professionals, enhancing treatment options and outcomes.
Greater competition in the field
Global spending on cancer medicine increased to $223 billion in 2023 and is projected to reach $409 billion by 2028. In 2023, 74% of the $223 billion spent on cancer medicine was concentrated in major developed markets (the United States, EU4+UK, and Japan), a trend that has remained stable over the past five years.
New products will need a strong value proposition to highlight clinical and cost-benefits. This makes it a crucial time for companies looking to grow their oncology businesses to focus on their capabilities and strategies when it comes to clinical trials, real-world evidence, and execution.
The oncology market’s increasing competition in 2024 and beyond will drive innovation and improve access to diverse treatment options, ultimately enhancing patient outcomes and offering professionals more tools to provide better cancer care.
Increased focus on early detection
Over the last few years, there has been a drastic change in the identification of cancer with advanced technologies. Artificial intelligence (AI) is becoming a promising option for improving health accuracy and patient outcomes.
In oncology, AI applications include early diagnosis, risk assessment, and treatment selection. Machine learning (which falls under the AI umbrella) has shown promising signs of predicting different types of cancer.
Closing the care gap
The Journal of Clinical Oncology (JCO) Global Oncology reports that over the next two decades, the number of cancer cases will rise more than 50% to 30.2 million. With this burden growing, the inequities in who can access cancer services grow with it.
Addressing the inequities in service access, social and financial impact, and survival rates is a critical challenge in the oncology community.
In its first year, the Close the Care Gap campaign focused on understanding inequities in care globally. The main objective at present is to issue a challenge to eliminate health inequities by addressing their root causes and supporting access to quality health services.
At IQVIA, our teams play a vital role in moving healthcare forward by leveraging innovative solutions to support equitable access to cancer care.
Elevate your career with oncology jobs at IQVIA
The global oncology market is undergoing a dynamic shift in 2024 and beyond.
With increased spending on R&D, new treatments emerging, greater competition among pharmaceutical companies, and increased advancements in early detection, more and more patients are receiving access to life-saving interventions and care.
The oncology market offers abundant opportunities for professionals seeking career growth while making a significant impact on patient lives and outcomes. That’s where IQVIA comes in.
If you’re looking to progress your career with an oncology focus, you can review our latest oncology jobs and help us change the face of healthcare.
Find out more about life at IQVIA
Did you know IQVIA has
4,600 data scientists
including statisticians and analytics developers
Did you know IQVIA has
86,000+ employees
from clinicians to data scientists each transforming healthcare in 100+ countries
Did you know IQVIA has
Excellent work-life balance
and is committed to this kind of culture
Did you know IQVIA has
56+ petabytes of unique data
including 1.2B+ non-identified patient records
Did you know IQVIA has
1,900+ epidemiologists
and real world insight experts
Did you know IQVIA cares about
Health and Wellbeing
for all its employees
Did you know IQVIA has
Countless development opportunities
for personal and professional growth
Did you know IQVIA has
Excellent work-life balance
and is committed to this kind of culture
Did you know IQVIA has
56+ petabytes of unique data
including 1.2B+ non-identified patient records
Did you know IQVIA cares about
Health and Wellbeing
for all its employees
Did you know IQVIA has
Countless development opportunities
for personal and professional growth
Did you know IQVIA has
4,600 data scientists
including statisticians and analytics developers
Did you know IQVIA has
1,900+ epidemiologists
and real world insight experts
Did you know IQVIA has
86,000+ employees
from clinicians to data scientists each transforming healthcare in 100+ countries
Related jobs
We are sorry but your search has returned no results.
Please try some of the links below to find what you are looking for:
Just following on from the amazing news I got yesterday I wanted to say a really special thank you for all the help and support you have provided throughout the entire recruitment process.
Once again I cannot thank you enough for not only approaching me with this opportunity but also for all the support you’ve given me along the way!
IQVIA has been behind my development to become a MSL. The contracts that I have worked on have allowed me to push clinical projects with a recent opportunity to manage a pilot scheme integrating e-detailing into an established field based team. The result was an increase in sales.
Since joining IQVIA I have had unrivalled support and development from my manager to enable me to aspire to move into secondary care. I feel like my career is strongly supported by my manager in order to maximise my potential.
A quick note to say thank you for your time this morning discussing my future career options. As you know I was feeling very conflicted about the right decision. Discussing the role with you gave me chance to clarify what is important to me.
A quick note to say thank you for your time this morning discussing my future career options. As you know I was feeling very conflicted about the right decision. Discussing the role with you gave me chance to clarify what is important to me.
IQVIA Related insights

Teaser
Medical Sales & ServicesContent Type
ArticlePublished
24/10/2024
Summary
We caught up with Diana Heres, a Service Development Executive at IQVIA Interface, on her career development journey with us so far. Diana shares her journey to help answer questions such as “How do
by
Ruth Lynn

Teaser
GeneralContent Type
ArticlePublished
08/10/2024
Summary
Recently, we interviewed Corinne Scott, Client Services Manager at IQVIA for her insight into how to decide a career change. Corinne shared her own journey and valuable advice with us to help answer
by
Corinne Scott

Teaser
SalesContent Type
ArticlePublished
04/10/2024
Summary
Virtual Sales has a growing presence in the healthcare and medical solutions industry, especially since the pandemic. Virtual Sales is set to be the new normal, even as we’ve emerged on the other side

Teaser
GeneralContent Type
ArticlePublished
27/09/2024
Summary
Kickstarting or switching your career is only made easier by having solid technical skills under your belt. Technical skills are expertise and specialised knowledge that you enhance throughout your c
by
Ruth Lynn

Teaser
SalesContent Type
ArticlePublished
18/09/2024
Summary
If you’re a recent or soon-to-be graduate of biomedical science, and have realised that a laboratory-based career may not be the right direction for you, you may be wondering what other career opti
by
Tracey Smith

Teaser
Medical Sales & ServicesContent Type
ArticlePublished
17/09/2024
Summary
Stepping into any role in the healthcare sector comes with its challenges, and being a successful medical sales representative is no exception. Whether you’re an experienced sales rep and feel confi
by
Ruth Lynn
.png)
Teaser
Medical Affairs & ServicesContent Type
ArticlePublished
13/08/2024
Summary
Medical Affairs is a fast-paced sector and the work is so varied that no two days will look the same. Medical affairs professionals working in the pharmaceutical, biotechnology and medical device in

Teaser
Medical Affairs & ServicesContent Type
ArticlePublished
31/07/2024
Summary
At IQVIA, we recruit for various roles within the MedTech sphere and we’re always looking for professionals keen to move healthcare forward. In this article, we’ll outline the market for MedTech so
by
Tracey Smith

Teaser
Clinical OperationsContent Type
ArticlePublished
23/07/2024
Summary
Clinical pharmacology, a specialised branch of biomedical science, holds a pivotal role in developing vital drugs and ensuring their effective use in patients. Clinical pharmacologists bridge the ga
by
Ruth Lynn

Teaser
SalesContent Type
ArticlePublished
23/07/2024
Summary
Oncologists focus on diagnosing and treating cancer while overseeing treatment and managing post-treatment care. The oncology drugs market worldwide is expected to reach a market volume of $268bn by
by
Ruth Lynn

Teaser
GeneralContent Type
ArticlePublished
17/07/2024
Summary
Market access is all about preparing a drug for market entry, and as such it’s a vitally important part of the drug development process and wider pharmaceutical industry. While for pharmaceutical an

Teaser
Medical Affairs & ServicesContent Type
ArticlePublished
04/07/2024
Summary
Becoming a Medical Science Liaison is a popular career choice for many Doctoral-level candidates seeking a meaningful role within the pharmaceutical industry where they can communicate scientifically
by
Tracey Smith
Recently viewed jobs